Abeona Therapeutics (ABEO) Competitors $5.75 -0.14 (-2.38%) Closing price 07/7/2025 04:00 PM EasternExtended Trading$5.79 +0.04 (+0.70%) As of 07/7/2025 05:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ABEO vs. VRDN, BGM, MNKD, NAGE, LQDA, PCRX, ABCL, WVE, NVAX, and NTLAShould you be buying Abeona Therapeutics stock or one of its competitors? The main competitors of Abeona Therapeutics include Viridian Therapeutics (VRDN), BGM Group (BGM), MannKind (MNKD), Niagen Bioscience (NAGE), Liquidia Technologies (LQDA), Pacira BioSciences (PCRX), AbCellera Biologics (ABCL), WAVE Life Sciences (WVE), Novavax (NVAX), and Intellia Therapeutics (NTLA). These companies are all part of the "med - biomed/gene" industry. Abeona Therapeutics vs. Its Competitors Viridian Therapeutics BGM Group MannKind Niagen Bioscience Liquidia Technologies Pacira BioSciences AbCellera Biologics WAVE Life Sciences Novavax Intellia Therapeutics Abeona Therapeutics (NASDAQ:ABEO) and Viridian Therapeutics (NASDAQ:VRDN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership, media sentiment and valuation. Which has more volatility and risk, ABEO or VRDN? Abeona Therapeutics has a beta of 1.51, meaning that its share price is 51% more volatile than the S&P 500. Comparatively, Viridian Therapeutics has a beta of 0.39, meaning that its share price is 61% less volatile than the S&P 500. Do institutionals & insiders hold more shares of ABEO or VRDN? 80.6% of Abeona Therapeutics shares are owned by institutional investors. 5.4% of Abeona Therapeutics shares are owned by insiders. Comparatively, 0.7% of Viridian Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has better valuation and earnings, ABEO or VRDN? Abeona Therapeutics has higher revenue and earnings than Viridian Therapeutics. Abeona Therapeutics is trading at a lower price-to-earnings ratio than Viridian Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbeona Therapeutics$3.50M84.05-$63.73M-$1.27-4.53Viridian Therapeutics$300K4,321.55-$269.95M-$3.85-4.13 Is ABEO or VRDN more profitable? Abeona Therapeutics has a net margin of 0.00% compared to Viridian Therapeutics' net margin of -102,092.39%. Viridian Therapeutics' return on equity of -70.61% beat Abeona Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Abeona TherapeuticsN/A -118.82% -52.48% Viridian Therapeutics -102,092.39%-70.61%-44.67% Do analysts prefer ABEO or VRDN? Abeona Therapeutics presently has a consensus target price of $19.25, suggesting a potential upside of 234.78%. Viridian Therapeutics has a consensus target price of $37.56, suggesting a potential upside of 136.35%. Given Abeona Therapeutics' stronger consensus rating and higher possible upside, equities research analysts plainly believe Abeona Therapeutics is more favorable than Viridian Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abeona Therapeutics 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Viridian Therapeutics 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.90 Does the media refer more to ABEO or VRDN? In the previous week, Abeona Therapeutics had 7 more articles in the media than Viridian Therapeutics. MarketBeat recorded 9 mentions for Abeona Therapeutics and 2 mentions for Viridian Therapeutics. Viridian Therapeutics' average media sentiment score of 0.87 beat Abeona Therapeutics' score of 0.26 indicating that Viridian Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abeona Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Viridian Therapeutics 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryAbeona Therapeutics beats Viridian Therapeutics on 10 of the 16 factors compared between the two stocks. Get Abeona Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ABEO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABEO vs. The Competition Export to ExcelMetricAbeona TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$301.31M$2.91B$5.52B$9.02BDividend YieldN/A2.44%5.24%4.08%P/E Ratio-4.5320.3027.1920.04Price / Sales84.05250.76395.22100.83Price / CashN/A41.7026.2128.59Price / Book5.697.397.925.55Net Income-$63.73M-$55.04M$3.17B$248.49M7 Day Performance3.23%2.51%1.79%4.87%1 Month Performance-14.69%-0.21%1.28%6.63%1 Year Performance19.79%3.41%33.32%20.38% Abeona Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABEOAbeona Therapeutics3.9812 of 5 stars$5.75-2.4%$19.25+234.8%+26.7%$301.31M$3.50M-4.5390VRDNViridian Therapeutics1.7843 of 5 stars$13.98-2.4%$37.56+168.6%+29.0%$1.17B$300K0.0050News CoverageBGMBGM GroupN/A$10.59-11.5%N/AN/A$1.16B$25.10M0.00298News CoverageAnalyst DowngradeMNKDMannKind2.5173 of 5 stars$3.74-0.5%$10.33+176.3%-31.0%$1.14B$285.50M37.40400Negative NewsNAGENiagen Bioscience1.293 of 5 stars$14.41+1.3%$19.50+35.3%N/A$1.12B$99.60M158.00120LQDALiquidia Technologies3.2022 of 5 stars$12.46-4.9%$26.89+115.8%+1.8%$1.12B$14M0.0050PCRXPacira BioSciences3.4122 of 5 stars$23.90+1.8%$26.44+10.6%+10.3%$1.09B$700.97M10.34720Positive NewsABCLAbCellera Biologics2.4345 of 5 stars$3.43-5.0%$8.33+143.0%+49.8%$1.08B$28.83M0.00500News CoverageAnalyst ForecastHigh Trading VolumeWVEWAVE Life Sciences4.4187 of 5 stars$6.50-2.5%$20.50+215.4%+29.1%$1.04B$108.30M-7.74240News CoverageNVAXNovavax4.4691 of 5 stars$6.30-1.1%$17.00+169.8%-44.5%$1.03B$682.16M2.381,990NTLAIntellia Therapeutics4.704 of 5 stars$9.38-1.9%$33.37+255.7%-55.0%$990.25M$57.88M0.00600 Related Companies and Tools Related Companies Viridian Therapeutics Alternatives BGM Group Alternatives MannKind Alternatives Niagen Bioscience Alternatives Liquidia Technologies Alternatives Pacira BioSciences Alternatives AbCellera Biologics Alternatives WAVE Life Sciences Alternatives Novavax Alternatives Intellia Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ABEO) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abeona Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Abeona Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
